SEC Form 4 · accession 0001232524-17-000004
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Russell J. Cox
Officer — EVP & COO
Period of report
Jan 18, 2017
Accepted (ET)
Jan 19, 2017 · 6:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Jan 18, 2017 | S | 1,000 | $125.00 | D | 50,095 | D | |
| Ordinary Shares | Jan 18, 2017 | S | 3,000 | $130.00 | D | 47,095 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2Includes 57 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2016.